Skip to main content
Top
Literature
1.
go back to reference Zeng G, Zhu W, Robertson WG, Penniston KL, Smith D, Pozdzik A et al (2022) International Alliance of Urolithiasis (IAU) guidelines on the metabolic evaluation and medical management of urolithiasis. Urolithiasis 51(1):4CrossRefPubMed Zeng G, Zhu W, Robertson WG, Penniston KL, Smith D, Pozdzik A et al (2022) International Alliance of Urolithiasis (IAU) guidelines on the metabolic evaluation and medical management of urolithiasis. Urolithiasis 51(1):4CrossRefPubMed
2.
go back to reference Williams JC Jr, Gambaro G, Rodgers A, Asplin J, Bonny O, Costa-Bauza A et al (2020) Urine and stone analysis for the investigation of the renal stone former: a consensus conference. Urolithiasis 49:1–16CrossRefPubMedPubMedCentral Williams JC Jr, Gambaro G, Rodgers A, Asplin J, Bonny O, Costa-Bauza A et al (2020) Urine and stone analysis for the investigation of the renal stone former: a consensus conference. Urolithiasis 49:1–16CrossRefPubMedPubMedCentral
3.
go back to reference Garrelfs SF, Frishberg Y, Hulton SA, Koren MJ, O’Riordan WD, Cochat P et al (2021) Lumasiran, an RNAi therapeutic for primary hyperoxaluria type 1. N Engl J Med 384(13):1216–1226CrossRefPubMed Garrelfs SF, Frishberg Y, Hulton SA, Koren MJ, O’Riordan WD, Cochat P et al (2021) Lumasiran, an RNAi therapeutic for primary hyperoxaluria type 1. N Engl J Med 384(13):1216–1226CrossRefPubMed
4.
go back to reference Dhayat NA, Bonny O, Roth B, Christe A, Ritter A, Mohebbi N et al (2023) Hydrochlorothiazide and prevention of kidney-stone recurrence. N Engl J Med 388(9):781–791CrossRefPubMed Dhayat NA, Bonny O, Roth B, Christe A, Ritter A, Mohebbi N et al (2023) Hydrochlorothiazide and prevention of kidney-stone recurrence. N Engl J Med 388(9):781–791CrossRefPubMed
5.
go back to reference Triozzi JL, Hsi RS, Wang G, Akwo EA, Wheless L, Chen HC et al (2023) Mendelian randomization analysis of genetic proxies of thiazide diuretics and the reduction of kidney stone risk. JAMA Netw Open 6(11):e2343290CrossRefPubMedPubMedCentral Triozzi JL, Hsi RS, Wang G, Akwo EA, Wheless L, Chen HC et al (2023) Mendelian randomization analysis of genetic proxies of thiazide diuretics and the reduction of kidney stone risk. JAMA Netw Open 6(11):e2343290CrossRefPubMedPubMedCentral
Metadata
Title
What’s new in the New International Alliance of Urolithiasis (IAU) guidelines
Authors
Amy Yau
David S. Goldfarb
Publication date
01-12-2024
Publisher
Springer Berlin Heidelberg
Keyword
Urolithiasis
Published in
Urolithiasis / Issue 1/2024
Print ISSN: 2194-7228
Electronic ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-023-01513-8

Other articles of this Issue 1/2024

Urolithiasis 1/2024 Go to the issue